CytoMed Therapeutics Stock (NASDAQ: GDTC) stock price, news, charts, stock research, profile.
You can purchase shares of CytoMed Therapeutics (NASDAQ:GDTC) through any online brokerage.
Other companies in CytoMed Therapeutics’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and Geovax Labs (NASDAQ:GOVX).
CytoMed Therapeutics has a consensus price target of $5.00.
The stock price for CytoMed Therapeutics (NASDAQ: GDTC) is $2.22 last updated November 14, 2024 at 11:59 AM EST.
There are no upcoming dividends for CytoMed Therapeutics.
CytoMed Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for CytoMed Therapeutics.
CytoMed Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.